Medicare Updated Articles Display Page

JF LOB Updated Artcles
Article ID Modified By Modified On Title
29093830 Kirby Schwartzbauer 02/10/2025 08:50:50 Open Public Meeting Announcement - Allergy Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - March 6, 2025
29093978 James Marko 02/10/2025 10:11:54 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - Published for Review and Comments
29093996 James Marko 02/10/2025 10:11:55 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - Published for Review and Comments
29094435 Kirby Schwartzbauer 02/10/2025 15:41:02 Review of Cost Report Exhibit Templates Webinar - 03/20/2025
29041393 Kirby Schwartzbauer 02/10/2025 11:31:53 Skin Substitutes - LCD Review Webinar - 09/18/2025
29093816 Kirby Schwartzbauer 02/10/2025 08:50:49 Open Public Meeting Announcement - Allergy Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - March 6, 2025
29095690 James Marko 02/11/2025 14:12:55 CMS Telehealth Frequently Asked Questions (FAQ)
29093752 James Marko 02/10/2025 08:46:22 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R9 - Effective November 18, 2024
29041379 Kirby Schwartzbauer 02/10/2025 11:31:50 Skin Substitutes - LCD Review Webinar - 09/18/2025
29095709 James Marko 02/11/2025 14:12:56 CMS Telehealth Frequently Asked Questions (FAQ)
29093770 James Marko 02/10/2025 08:46:25 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R9 - Effective November 18, 2024
JD LOB Updated Artcles
Article ID Modified By Modified On Title
29095312 Kirby Schwartzbauer 02/11/2025 10:37:02 Ventilators Webinar - 03/25/2025
29095208 Kirby Schwartzbauer 02/11/2025 10:32:09 Therapeutic Shoes for Persons with Diabetes Webinar - 03/26/2025
29095343 Kirby Schwartzbauer 02/11/2025 11:12:39 Continued Coverage for Continuous Glucose Monitor (CGM)
JE LOB Updated Artcles
Article ID Modified By Modified On Title
29093734 James Marko 02/10/2025 08:46:19 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R9 - Effective November 18, 2024
29095675 James Marko 02/11/2025 14:12:55 CMS Telehealth Frequently Asked Questions (FAQ)
29095726 James Marko 02/11/2025 14:12:57 CMS Telehealth Frequently Asked Questions (FAQ)
29093942 James Marko 02/10/2025 10:11:52 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - Published for Review and Comments
29093788 Kirby Schwartzbauer 02/10/2025 08:50:47 Open Public Meeting Announcement - Allergy Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - March 6, 2025
29041351 Kirby Schwartzbauer 02/10/2025 11:31:43 Skin Substitutes - LCD Review Webinar - 09/18/2025
29093802 Kirby Schwartzbauer 02/10/2025 08:50:48 Open Public Meeting Announcement - Allergy Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - March 6, 2025
29041365 Kirby Schwartzbauer 02/10/2025 11:31:46 Skin Substitutes - LCD Review Webinar - 09/18/2025
29093960 James Marko 02/10/2025 10:11:52 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) - Published for Review and Comments
29093716 James Marko 02/10/2025 08:46:17 Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R9 - Effective November 18, 2024
29094421 Kirby Schwartzbauer 02/10/2025 15:41:06 Review of Cost Report Exhibit Templates Webinar - 03/20/2025
JA LOB Updated Artcles
Article ID Modified By Modified On Title
29095357 Kirby Schwartzbauer 02/11/2025 11:12:39 Continued Coverage for Continuous Glucose Monitor (CGM)
29095194 Kirby Schwartzbauer 02/11/2025 10:32:13 Therapeutic Shoes for Persons with Diabetes Webinar - 03/26/2025
29095298 Kirby Schwartzbauer 02/11/2025 10:36:59 Ventilators Webinar - 03/25/2025